Join
Live feed
·
INSIDERFilingvia Quantisnow
Blueprint Medicines Corporation logo

Director Albers Jeffrey W. sold $512,021 worth of shares (5,766 units at $88.80), decreasing direct ownership by 4% to 146,630 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
BPMC· Blueprint Medicines Corporation
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BPMC (Blueprint Medicines Corporation) and more on Quantisnow.